Market closed
Anixa Biosciences/$ANIX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Anixa Biosciences
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
Ticker
$ANIX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
-
Website
ANIX Metrics
BasicAdvanced
$82M
Market cap
-
P/E ratio
-$0.39
EPS
0.87
Beta
-
Dividend rate
Price and volume
Market cap
$82M
Beta
0.87
52-week high
$5.13
52-week low
$2.15
Average daily volume
97K
Financial strength
Current ratio
11.312
Quick ratio
10.556
Long term debt to equity
1.029
Total debt to equity
1.145
Management effectiveness
Return on assets (TTM)
-34.65%
Return on equity (TTM)
-55.24%
Valuation
Price to book
3.78
Price to tangible book (TTM)
3.78
Price to free cash flow (TTM)
-9.665
Growth
Revenue change (TTM)
-100.00%
Earnings per share change (TTM)
13.95%
3-year earnings per share growth (CAGR)
-1.82%
What the Analysts think about ANIX
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Anixa Biosciences stock.
ANIX Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
ANIX Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Anixa Biosciences stock?
Anixa Biosciences (ANIX) has a market cap of $82M as of December 31, 2024.
What is the P/E ratio for Anixa Biosciences stock?
The price to earnings (P/E) ratio for Anixa Biosciences (ANIX) stock is 0 as of December 31, 2024.
Does Anixa Biosciences stock pay dividends?
No, Anixa Biosciences (ANIX) stock does not pay dividends to its shareholders as of December 31, 2024.
When is the next Anixa Biosciences dividend payment date?
Anixa Biosciences (ANIX) stock does not pay dividends to its shareholders.
What is the beta indicator for Anixa Biosciences?
Anixa Biosciences (ANIX) has a beta rating of 0.87. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.